AEGON Asset Management (UK)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,296
| Closed | -$1.29M | – | 184 |
|
|
2026
Q1 | $1.29M | Sell |
2,296
-23,772
| -91% | -$15.2M | 0.02% | 146 |
|
|
2025
Q4 | $17.6M | Sell |
26,068
-1,247
| -5% | -$849K | 0.21% | 100 |
|
|
2025
Q3 | $17.4M | Sell |
27,315
-20,993
| -43% | -$12.7M | 0.21% | 102 |
|
|
2025
Q2 | $25.9M | Buy |
48,308
+16,237
| +51% | +$7.76M | 0.33% | 76 |
|
|
2025
Q1 | $13.5M | Sell |
32,071
-1,795
| -5% | -$779K | 0.2% | 108 |
|
|
2024
Q4 | $14M | Sell |
33,866
-6,036
| -15% | -$2.65M | 0.18% | 107 |
|
|
2024
Q3 | $20.2M | Buy |
39,902
+352
| +0.9% | +$171K | 0.27% | 90 |
|
|
2024
Q2 | $19.3M | Sell |
39,550
-27,399
| -41% | -$13.8M | 0.27% | 87 |
|
|
2024
Q1 | $36.1M | Sell |
66,949
-236
| -0.4% | -$129K | 0.54% | 53 |
|
|
2023
Q4 | $37.3M | Buy |
+67,185
| New | +$31.5M | 0.59% | 48 |
|
|
2023
Q2 | $34.2M | Buy |
68,181
+62,781
| +1,163% | +$30.1M | 0.55% | 50 |
|
|
2023
Q1 | $2.7M | Hold |
5,400
| – | – | 0.05% | 128 |
|
|
2022
Q4 | $2.2M | Buy |
5,400
+1,157
| +27% | +$449K | 0.04% | 141 |
|
|
2022
Q3 | $1.38M | Sell |
4,243
-263
| -6% | -$96.6K | 0.03% | 139 |
|
|
2022
Q2 | $1.58M | Buy |
4,506
+370
| +9% | +$151K | 0.03% | 152 |
|
|
2022
Q1 | $2.26M | Sell |
4,136
-1,017
| -20% | -$535K | 0.03% | 140 |
|
|
2021
Q4 | $3.39M | Buy |
5,153
+114
| +2% | +$71.6K | 0.04% | 135 |
|
|
2021
Q3 | $3.13M | Sell |
5,039
-749
| -13% | -$503K | 0.04% | 135 |
|
|
2021
Q2 | $3.65M | Hold |
5,788
| – | – | 0.05% | 131 |
|
|
2021
Q1 | $2.83M | Sell |
5,788
-1,219
| -17% | -$611K | 0.04% | 138 |
|
|
2020
Q4 | $3.5M | Hold |
7,007
| – | – | 0.05% | 121 |
|
|
2020
Q3 | $2.75M | Sell |
7,007
-633
| -8% | -$234K | 0.06% | 108 |
|
|
2020
Q2 | $2.52M | Sell |
7,640
-1,281
| -14% | -$371K | 0.06% | 106 |
|
|
2020
Q1 | $2.16M | Hold |
8,921
| – | – | 0.06% | 104 |
|
|
2019
Q4 | $2.33M | Hold |
8,921
| – | – | 0.06% | 119 |
|
|
2019
Q3 | $2.43M | Hold |
8,921
| – | – | 0.06% | 110 |
|
|
2019
Q2 | $2.46M | Hold |
8,921
| – | – | 0.07% | 100 |
|
|
2019
Q1 | $1.99M | Hold |
8,921
| – | – | 0.06% | 101 |
|
|
2018
Q4 | $1.66M | Hold |
8,921
| – | – | 0.05% | 111 |
|
|
2018
Q3 | $2.23M | Sell |
8,921
-1,447
| -14% | -$351K | 0.05% | 110 |
|
|
2018
Q2 | $2.26M | Hold |
10,368
| – | – | 0.06% | 105 |
|
|
2018
Q1 | $1.98M | Sell |
10,368
-1,813
| -15% | -$335K | 0.05% | 124 |
|
|
2017
Q4 | $1.91M | Hold |
12,181
| – | – | 0.05% | 124 |
|
|
2017
Q3 | $1.89M | Buy |
12,181
+4,019
| +49% | +$635K | 0.05% | 117 |
|
|
2017
Q2 | $1.32M | Sell |
8,162
-250
| -3% | -$40.6K | 0.04% | 135 |
|
|
2017
Q1 | $1.3M | Sell |
8,412
-132
| -2% | -$18.2K | 0.03% | 133 |
|
|
2016
Q4 | $1M | Buy |
+8,544
| New | +$975K | 0.03% | 166 |
|
Other funds holding IDXX
AEGON Asset Management (UK)'s IDXX Position: Q2 2026 in Review
AEGON Asset Management (UK) sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 2,296 shares — an estimated $1.29M sold.
AEGON Asset Management (UK) first reported a position in IDXX in Q4 2016 and held it in 37 quarters. The position peaked at $37.3M in Q4 2023. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- AEGON Asset Management (UK) reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
- AEGON Asset Management (UK) sold 2,296 Idexx Laboratories shares in Q2 2026, an estimated $1.29M.
- AEGON Asset Management (UK) first reported a position in Idexx Laboratories in Q4 2016 and held it in 37 quarters.
- AEGON Asset Management (UK)'s Idexx Laboratories position peaked at $37.3M in Q4 2023.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.